Zantac Cancer Litigation

Case: In Re: Zantac (Ranitidine) Products Liability Litigation, 9:20-md-02924
Court: United States District Court, Southern District of Florida


Wallace Miller represents clients who have taken the heartburn medication Zantac and have been diagnosed with cancer as a result of consuming the drug. Zantac (generic name ranitidine) is a medication that was used by millions of Americans to treat heartburn, acid reflux, and other stomach conditions.

Zantac was available both over the counter and by prescription, and was one of the most popular drugs used in the United States for decades. In 2020, the FDA removed Zantac from the market after finding elevated levels of a cancer-causing compound, known as NDMA, in the drug. A growing body of evidence shows that NDMA is formed when Zantac is broken down in body, leading to cancers of the gastrointestinal tract and other organs in the body. A Multidistrict litigation (MDL) was established in 2020 in the United States District Court for the Southern District of Florida, which consolidated many of the cases for pre-trial purposes. Lawsuits against the manufactures of Zantac allege failure to warn, design defect, and other claims.

At Wallace Miller, we believe the manufacturers of Zantac, and other responsible parties, need to be held accountable for their wrongful conduct. Our team is hard at work to secure recoveries for our clients diagnosed with cancer as a result of taking Zantac. Contact us for a free case evaluation.

Tell Us Your Story